Intrathecal and Systemic Concentration of NT-proBNP in Patients with Severe Traumatic Brain Injury
- 1 June 2006
- journal article
- research article
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 23 (6) , 943-949
Abstract
Outcome of patients suffering from traumatic brain injury (TBI) depends on the development of secondary brain damage. In this context, recent studies underlined the role of the natriuretic peptides— atrial natriuretic peptide and brain natriuretic peptide (BNP)—in aneurysmatic subarachnoidal hemorrhage (SAH). Especially BNP correlates with intracranial pressure and clinical outcome after SAH. Since its role in TBI remains unclear, the intracranial and systemic concentrations of N-terminal (NT)–proBNP were analyzed in patients suffering from severe TBI. We measured NT-proBNP levels in cerebrospinal fluid (CSF) and serum of 14 patients suffering from severe TBI (GCS ≤8 points) and 10 healthy control patients, using proBNP® assay (Roche® Diagnostics). Samples were collected after placement of a ventricular catheter, and at 12, 24, 48, and 72 h after TBI. CSF/serum albumin ratio (Q < a) was daily calculated. At 90 days after TBI, outcome was evaluated using the Glasgow Outcome Scale (GOS). In patients exhibiting a mean ICP of >15 mm Hg (n = 6), the serum (800 ± 150 pg/mL) and CSF levels (55 ± 9 pg/mL) of NT-proBNP were significantly increased after 24 h, as compared to patients with ICP ≤15 mm of Hg (n = 8) as well as to control group. However, Qa as well as GOS did not significantly differ among both groups. For the first time, we evaluated intrathecal and systemic NT-proBNP concentrations in patients suffering from severe TBI. Interestingly, NT-proBNP in CSF and serum was significantly elevated in patients exhibiting an ICP of >15 mm Hg. Further studies are currently performed to elucidate the physiologic role of NT-proBNP in TBI.Keywords
This publication has 22 references indexed in Scilit:
- Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsisCritical Care Medicine, 2004
- Lessons from epidemiologic studies in clinical trials of traumatic brain injury2004
- Differential Effects of Atrial Natriuretic Peptide on the Brain Water and Sodium after Experimental Cortical Contusion in the RatJournal of Cerebral Blood Flow & Metabolism, 2003
- B-type natriuretic peptide in cardiovascular diseaseThe Lancet, 2003
- The neuro‐cardio‐endocrine response to acute subarachnoid haemorrhageClinical Endocrinology, 2002
- Differential Secretion of Atrial and Brain Natriuretic Peptide in Critically Ill PatientsAnesthesia & Analgesia, 2001
- Recommendations for Intracranial Pressure Monitoring TechnologyJournal of Neurotrauma, 2000
- Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhageThe Lancet, 1997
- Role of endothelin in pial artery vasoconstriction and altered responses to vasopressin after brain injuryJournal of Neurosurgery, 1996
- ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical ScaleThe Lancet, 1975